Elections

Subterms

    More stories

    • 125 Shares165 Views

      in Elections

      New Columbia President Attacked by Stefanik Over 2023 Text Message

      by

      Elise Stefanik, a prominent Republican, questioned Claire Shipman’s commitment to protecting Jewish students. Ms. Shipman pledged “to build on the significant progress we’ve made.”Claire Shipman is only days into her job as acting president of Columbia University but is already being targeted by a prominent House Republican who questions her commitment to fighting antisemitism on campus.Ms. Shipman, in a private text message in December 2023 to Nemat Shafik, who was then Columbia’s president, referred to congressional hearings into campus antisemitism as “capital hill nonsense,” according to a transcript of the exchange released by the House Committee on Education and the Workforce as part of an investigative report last year.The comment is coming back to haunt Ms. Shipman. Representative Elise Stefanik, who is remaining in the House after President Trump withdrew her nomination to be U.S. ambassador to the United Nations, seized on the remark during a television interview Sunday, predicting that Ms. Shipman will not last long in her new position.“It’s already come out that she has criticized and belittled the House investigation and the accountability measures and has failed to protect Jewish students,” Ms. Stefanik said on Fox News’s “Sunday Morning Futures.”“It’s untenable for her to be in this position, and I think it is only going to be a matter of weeks before she’s forced to step down as well,” she added.On X, Ms. Stefanik, whose pointed questioning of Ivy League presidents about antisemitism during the committee hearings sparked the departures of the presidents of Harvard and the University of Pennsylvania, gave other details.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 150 Shares110 Views

      in Elections

      Crucial Week for Trump: New Tariffs and Elections Will Test His Momentum

      by

      Down-ballot races in Florida and Wisconsin are seen as a referendum on the White House, while the president’s to-be-announced reciprocal tariff plan is increasingly worrying investors and consumers.President Trump’s political momentum will face a major test this week as Democrats try to turn various down-ballot races into a referendum on the White House, and Mr. Trump’s long-promised tariffs risk rattling allies and consumers alike.A State Supreme Court election in Wisconsin on Tuesday is seen as an indicator of support for Mr. Trump, particularly after Elon Musk and groups he funds spent more than $20 million to bolster Mr. Trump’s preferred candidate. White House officials have also been increasingly concerned with the unusually competitive race on Tuesday for a deep-red House seat in Florida left vacant after Representative Michael Waltz stepped down to serve as Mr. Trump’s national security adviser.The White House is hoping victories in those races will tighten Mr. Trump’s grip on the Republican Party as his team seeks to overcome the backlash from its inadvertent sharing of military plans on a commercial app with a journalist.The Florida election is critical for Republicans, who hold a narrow majority in the House as they try to pass the president’s agenda. The outcome of the Wisconsin race, in a battleground state that Mr. Trump narrowly won last year, could be a reflection of voters’ views on the president’s gutting of the federal work force, his crackdown on illegal immigration and his moves to purge diversity, equity and inclusion initiatives.“It’s a big race,” Mr. Trump said of the Wisconsin judicial contest on Monday while signing executive orders in the Oval Office. “Wisconsin is a big state politically, and the Supreme Court has a lot to do with elections in Wisconsin.”Mr. Trump is also expected to reveal the details of his reciprocal tariff plan on Wednesday. He has labeled it “Liberation Day,” saying the nation will finally break free of past trade relationships that he argues have cheated the United States. Investors, however, are growing more concerned that the tariffs could fuel inflation and slow consumer spending, potentially driving up economic anxieties among voters.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 63 Shares119 Views

      in Elections

      What’s at Stake in Wisconsin

      by

      Elon Musk sees the state’s Supreme Court race as a way of preserving Republicans’ power in Washington.About nine minutes into his time onstage in Green Bay last night, Elon Musk neatly explained why he — a billionaire technologist who is already distracted by a little project in Washington — had poured $20 million and hours of his time into a Wisconsin Supreme Court election.“What’s happening on Tuesday is a vote for which party controls the U.S. House of Representatives,” he said.The party that controls the chamber, he added, “controls the country, which then steers the course of Western civilization.”Anybody not currently serving in the House might consider that last part to be hyperbole. But Musk’s words revealed his stated motivation behind his involvement on behalf of the conservative candidate, Judge Brad Schimel: He sees it as a way of preserving Republicans’ power well beyond Wisconsin.He has a point. Democrats don’t talk about it in quite such existential terms, but they are widely expected to challenge the narrowly divided state’s congressional maps, which currently favor Republicans, if voters maintain a liberal majority on the Supreme Court.With Republicans holding a thin majority in the House now, any changes that make it easier for Democrats to win seats could have major consequences in midterm elections next year.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 125 Shares137 Views

      in Elections

      Trump Administration Has Begun a War on Science, Researchers Say

      by

      Nearly 2,000 scientists urged that Congress restore funding to federal agencies decimated by recent cuts.Some 1,900 leading researchers accused the Trump administration in an open letter on Monday of conducting a “wholesale assault on U.S. science” that could set back research by decades and that threatens the health and safety of Americans.The letter’s signatories, all of them elected members of the National Academies of Sciences, Engineering and Medicine, warned of the damage being done by layoffs at health and science agencies and cuts and delays to funding that has historically supported research inside the government and across American universities.“For over 80 years, wise investments by the U.S. government have built up the nation’s research enterprise, making it the envy of the world,” the letter said. “Astoundingly, the Trump administration is destabilizing this enterprise by gutting funding for research, firing thousands of scientists, removing public access to scientific data and pressuring researchers to alter or abandon their work on ideological grounds.”Read the LetterResearchers at academic institutions nationwide say that U.S. science is being dismantled.Read Document 75 pagesThe letter said that many universities and research institutions had so far “kept silent to avoid antagonizing the administration and jeopardizing their funding.” But, it said, “the nation’s scientific enterprise is being decimated.”The signatories called on Americans to appeal to Congress to protect scientific funding.With Elon Musk’s efforts to cut spending and President Trump’s crackdown on institutions he sees as ideological enemies, the administration has sought to dismantle parts of the federal government’s scientific funding apparatus.We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 38 Shares183 Views

      in Elections

      Read the Letter

      by

      Pamela C. Ronald, PhD
      Distinguished Professor in the Department of
      Plant Pathology and the Genome Center
      University of California, Davis
      Michael Rosbash, PhD
      Peter Gruber Professor of Neuroscience
      Brandeis University
      Sara Rosenbaum, JD
      Professor Emerita Health Law and Policy
      George Washington University
      Irwin Rosenberg, MD
      University Professor Emeritus in Medicine and
      Nutrition
      Tufts University
      Steven A. Rosenberg, MD, PhD
      Chief, Surgery Branch
      National Cancer Institute
      Mendel Rosenblum, PhD
      Cheriton Family Professor of Engineering
      Stanford University
      Linda Rosenstock, MD, MPH
      Dean Emeritus and Professor
      University of California, Los Angeles
      Linda Rosenstock, MD, MPH
      Dean Emeritus and Professor
      UCLA
      Meredith Rosenthal, PhD
      Professor of Health Economics and Policy
      Harvard T.H. Chan School of Public Health
      David K. Rosner, PhD
      Ronald Lauterstein Professor
      Columbia University
      Lainie Friedman Ross, MD, PhD
      Dean’s Professor and Chair, Department of
      Health Humanities and Bioethics, Director,
      Paul M Schyve MD Center for Bioethics
      University of Rochester
      Cornelius Rosse, MD, DSC
      Professor Emeritus
      University of Washington, School of Medicine
      Peter J. Rossky, PhD
      Professor
      Rice University
      Alvin E. Roth, PhD
      Professor
      Stanford University
      James A. Roth, DVM, PhD
      Distinguished Professor
      Iowa State University
      Lucia B. Rothman-Denes, PhD
      Haig P. Papazian Distinguished Service
      Professor, Department of Molecular Genetics
      and Cell Biology
      University of Chicago
      Martine F Roussel, PhD
      Professor
      St. Jude Children’s Research Hospital
      Ali Rowhani-Rahbar, MD, MPH, PhD
      Professor
      University of Washington
      Diane Rowland, ScD
      Executive Vice President Emerita
      Kaiser Family Foundation
      John L. Rubenstein, MD, PhD
      Professor of Psychiatry
      University of California, San Francisco
      Ronitt A. Rubinfeld, PhD
      Edwin Sibley Webster Professor of Electrical
      Engineering and Computer Science
      MIT
      David R. Rubinow, MD
      Chair Emeritus and Professor
      University of North Carolina at Chapel Hill
      Alexander Rudensky, PhD
      Chairman, Immunology Program, Lloyd Old
      Chair in Clinical Investigation, Investigator,
      Howard Hughes Medical Institute
      Memorial Sloan Kettering Cancer Center
      Joan V. Ruderman, PhD
      Nelson Professor of Cell Biology (Emeritus)
      Harvard Medical School
      Roberta L. Rudnick, PhD
      Distinguished Professor
      University of California, Santa Barbara
      David W. Russell, PhD
      Emeritus Professor of Molecular Genetics
      University of Texas Southwestern Medical
      Center
      58 More

    • 175 Shares156 Views

      in Elections

      As Rescuers Work at Collapsed Bangkok Building, Those Who Found Love There Await News

      by

      The Bangkok building razed by Friday’s quake employed men and women who had found love at work. Despite glimmers of hope, many were still beneath the rubble.The rescue teams at the collapsed office tower in Bangkok thought they’d found a miracle on Sunday night: a channel into the basement, leading to a wide-open space where workers still unaccounted for might have lived through Friday’s giant earthquake.“We thought for sure we’d find someone,” said Piyalux Thinkaew, chief of operations for the Ruamkatanyu Foundation, one of Thailand’s leading emergency organizations. “It was a whole room. It was big.”Around a dozen rescuers stepped in. They were from Thailand, China, the United States and Israel. They could see the foundation’s pillars holding strong. But the room was empty.The next morning, another wisp of hope arrived when infrared sensors found potential signs of life. The recovery work fell silent. But after a while, there was nothing. No one was pulled out alive or dead on Monday by the time the clock ticked past the so-called golden window — the 72 hours in which survival is most likely.“Hope is dimming,” Mr. Piyalux said. “We’re very disappointed.”Was rescue becoming recovery? Not officially. Around 80 workers were still under the pile of chest-crushing rubble and steel that was tall enough to be seen from blocks away. Rescue workers said they were racing against time, as if 72 hours really meant 96, or maybe more.Family members and acquaintances of the missing waited for news on Monday.Lauren DeCicca/Getty ImagesWe are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More

    • 75 Shares165 Views

      in Elections

      Why the Right Still Embraces Ivermectin

      by

      Five years after the pandemic began, interest in the anti-parasitic drug is rising again as right-wing influencers promote it — and spread misinformation about it.Joe Grinsteiner is a gregarious online personality who touts the anti-parasitic drug ivermectin. In a recent Facebook video, he produced a tube of veterinary-grade ivermectin paste — the kind made for deworming horses.He gave the tube a squeeze. Then he licked a slug of the stuff, and gulped.“Yum,” Mr. Grinsteiner said in the Feb. 25 video, one of a number of ivermectin-related posts he has made that have drawn millions of views on Facebook this year. “Actually, that tastes like dead cancer.”Ivermectin, a drug proven to treat certain parasitic diseases, exploded in popularity during the pandemic amid false claims that it could treat or prevent Covid-19. Now — despite a persistent message from federal health officials that its medical benefits are limited — interest in ivermectin is rising again, particularly among American conservatives who are seeing it promoted by right-wing influencers.Mr. Grinsteiner, 54, is a Trump supporter and country music performer who lives in rural Michigan. He has claimed in his videos that ivermectin cured his skin cancer, as well as his wife’s cervical cancer. In a video last month, he said a woman told him her nonverbal autistic child had become verbal after using ivermectin. In a recent phone interview, Mr. Grinsteiner said that he takes a daily dose of ivermectin to maintain his general well-being.There is no evidence to support people taking ivermectin to treat cancer or autism. Yet Mr. Grinsteiner believes that the medical and political establishments just want to keep average people from discovering the healing powers of a relatively affordable drug. We are having trouble retrieving the article content.Please enable JavaScript in your browser settings.Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.Thank you for your patience while we verify access.Already a subscriber? Log in.Want all of The Times? Subscribe. More